24th Jul 2020 17:23
ValiRx PLC - clinical stage biotechnology company - Says broker option allowing current investors to participate in placing was fully subscribed and raised GBP300,700 through issue of 4.0 million shares at 7.5 pence each.
Current stock price: 7.88 pence
Year-to-date change: down 47%
By Eric Cunha; [email protected]
Copyright 2020 Alliance News Limited. All Rights Reserved.
Related Shares:
ValiRx